Ken Griffin Shockwave Medical, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$191.17 - $325.63 $2.64 Million - $4.49 Million	-13,800 Reduced 13.76%	86,500 $28.2 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $5.57 Million - $7.46 Million	34,600 Added 52.66%	100,300 $19.1 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $5.67 Million - $8.29 Million	29,200 Added 80.0%	65,700 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $2.23 Million - $3.03 Million	10,000 Added 37.74%	36,500 $10.4 Million
Q1 2023 May 15, 2023	SELL	$175.41 - $217.92 $1.05 Million - $1.31 Million	-6,000 Reduced 18.46%	26,500 $5.75 Million
Q4 2022 Feb 14, 2023	SELL	$204.38 - $296.82 $6.03 Million - $8.76 Million	-29,500 Reduced 47.58%	32,500 $6.68 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $3.61 Million - $5.74 Million	18,500 Added 42.53%	62,000 $17.2 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.